Product Information
- 1,3,5-Triazine-2,4-diamine, 3,6-dihydro-N2,N2,6-trimethyl-, (6R)-
- 1,3,5-Triazine-2,4-diamine,1,6-dihydro-N,N,6-trimethyl-, (6R)- (9CI)
- 1,3,5-Triazine-2,4-diamine, 1,6-dihydro-N,N,6-trimethyl-, (6R)-
- R-(4-Imino-6-methyl-1,4,5,6-tetrahydro-[1,3,5]trazin-2-yl)dimethylamine
- R-(4-Imino-6-methyl-1,4,5,6-tetrahydro-[1,3,5]triazin-2-yl)dimethylamine
- Imeglimin
- EMD 387008
Imeglimin is a drug that acts as an antidiabetic agent by targeting energy metabolism. It has been shown to reduce the levels of blood glucose and improve insulin sensitivity in patients with type 2 diabetes. Imeglimin also reduces kidney fibrosis and improves mitochondrial membrane potential, redox potential, and ATP levels in liver cells. Imeglimin has significant interactions with other drugs that affect energy metabolism, such as metformin and phenformin. These drugs should be avoided in patients taking imeglimin to avoid toxic effects on the heart, liver, or kidneys. Imeglimin is metabolized by CYP2C19 into its active form imeglimine.
Chemical properties
Technical inquiry about: 3D-AGB35165 Imeglimin
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
